AI-generated summary
The authors retrospectively reviewed medical and dental records of hematopoietic cell transplantation patients over a 15-year period to assess whether different photobiomodulation protocols for oral mucositis were linked to immediate or late adverse effects. They report that no immediate adverse effect or secondary oral malignancy was associated with the therapy, and they describe the protocols used as safe. Severe oral mucositis was infrequent, and when present it was associated with lower overall survival.
- Who or what was studied
- Patients undergoing autologous or allogeneic hematopoietic cell transplantation
- Limits stated in the abstract
- The abstract describes a retrospective design, which limits the ability to establish causation and relies on recorded clinical data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Oral mucositis, Dosimetry. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.